Med Tech Earnings Calls In Brief
This article was originally published in The Gray Sheet
Executive Summary
Taxus, Express 2 recall update: Boston Scientific's 96,000 unit recall of Taxus paclitaxel-eluting and Express2 stents is "complete in the field and restocking has been completed" in the U.S., VP-Cardiovascular Paul LaViolette states in a Q2 earnings call July 27. "The recall process in labs...represent[s] a little over 1,200 total accounts. We have shipped over 40,000 replenishment units over the past several days and that has gone back to about 97% of all accounts that had originally held any Taxus inventory. Forty-eight hours of activity allowed us to restock" the U.S., he added (1"The Gray Sheet" July 26, 2004, p. 10). High-profile hospital Brigham & Women's in Boston resumed use of Taxus the week of July 26. The firm also stated FDA's inspection of its Maple Grove, Minn. facility in response to the recall concluded July 22 with zero Form-483 observations. Boston Scientific revenue rose 71% to $1.46 bil. in Q2, due primarily to increased Taxus sales. The product brought in $597 mil. in worldwide sales and represented 92% of the firm's total stent revenue. In the U.S., Taxus sales totaled $468.4 mil. in Q2, despite the recall...
You may also be interested in...
Boston Scientific Applies Lessons From Taxus Recall To Ireland Plant
Stent delivery catheter flaws that provoked a 96,000-unit recall will be prevented by newly installed laser control software at Boston Scientific's Galway, Ireland facility, according to the firm
Wright, Smith & Nephew Vie To Enter U.S. Hip Resurfacing Market First
Wright Medical hopes to bolster orthopedic hip growth in 2005 and beyond by becoming the first firm to offer a product in the potentially lucrative U.S. hip resurfacing market
Advanced Bionics Grab Gives Boston Scientific Neurostim Growth Platforms
Boston Scientific is prepared to pay up to $4 bil. for neuromodulation systems developer Advanced Bionics as a means to add high-growth potential beyond its core vascular intervention business